Effects of dibutyryl cyclic AMP on ventricular vulnerability during atrioventricular block in dog.
The effects of dibutyryl cyclic AMP (DBcAMP) on ventricular vulnerability during complete atrioventricular block (CAVB) were studied one week after transarterial electrical ablation of the AV junction in 18 closed-chest dogs. All dogs exhibited CAVB and a stable ventricular escape rhythm with a mean cycle length of 1812 +/- 638 ms. After the administration of DBcAMP at a rate of 0.1 mg/kg/min for 30 min, the ventricular cycle length was significantly shortened, and the QTc interval was slightly prolonged, although the QT interval did not change. The ventricular fibrillation threshold after the administration of DBcAMP was significantly increased (from 12.2 +/- 3 84 to 18.4 +/- 5.08 mA, p less than 0.01). Thus, it was demonstrated that DBcAMP exhibited suppressive effects on the ventricular vulnerability in the experimentally induced CAVB.
Kumagai
K
K
Department of Internal Medicine, Fukuoka University, School of Medicine, Japan.
Tashiro
E
E
Tashiro
N
N
Moroe
K
K
Hiroki
T
T
Arakawa
K
K
D000818:Animals; D001283:Atrioventricular Node / Q000187:drug effects / Q000601:surgery; D003994:Bucladesine / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D004562:Electrocardiography / Q000187:drug effects*; D004564:Electrocoagulation; D006327:Heart Block / Q000188:drug therapy* / Q000503:physiopathology; D013610:Tachycardia / Q000188:drug therapy / Q000503:physiopathology; D016171:Torsades de Pointes / Q000188:drug therapy / Q000503:physiopathology
D003994:Bucladesine